Tag: Neuromuscular Disorders Pipeline

NASH Emerging Therapies: Transforming the Future of Treatment Nonalcoholic steatohepatitis (NASH) is a progressive liver disease characterized by inflammation and liver damage due to fat accumulation, not related to alcohol consumption. As the prevalence of NASH rises globally, driven by increasing rates of obesity and diabetes, the need for effective therapies becomes increasingly critical. The…

Nonalcoholic Steatohepatitis : A Rising Epidemic Nonalcoholic Steatohepatitis is increasingly recognized as a significant public health concern. Characterized by liver inflammation and damage due to fat accumulation, NASH is part of a broader spectrum of Nonalcoholic Fatty Liver Disease (NAFLD). Unlike alcoholic liver disease, NASH arises in individuals with minimal or no alcohol consumption. Its…